KURA Kura Oncology, Inc. - Common Stock
$12,53
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$7–$13
95% of range
Analystenbewertung
BUY
22 analysts
Kursziel
$32
+155% upside
P/E (TTM)
-3.9
ROE
-116.2%
Nettogewinnmarge
-413.0%
KURA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$12.53
Marktkapitalisierung
$1.10B
P/E (TTM)
-3.9
EPS (TTM)
$-3.18
Umsatz (TTM)
$67M
Dividendenrendite
—
ROE
-116.2%
Verschuldungsgrad
0.1
52W-Spanne
$7 – $13
KURA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$67M
2023-12-31
→
2025-12-31
EPS
$-3.18
2020-12-31
→
2025-12-31
Freier Cashflow
$-71M
2020-12-31
→
2025-12-31
Margen
-413.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
KURA
Peer-Median
P/E (TTM)
-3.9
—
P/S (TTM) (K/V (TTM))
16.3
12.8
P/B (K/B)
6.3
3.4
EV / EBITDA
-3.2
—
Price / FCF (Kurs / FCF)
-15.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
KURA
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-449.9%
—
Net Profit Margin (Nettogewinnmarge)
-413.0%
-294.4%
ROA
-37.2%
-31.3%
ROE
-116.2%
-38.1%
ROIC
-165.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
KURA
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.1
—
Current Ratio (Liquiditätsgrad)
6.1
10.9
Quick Ratio
1.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
KURA
Peer-Median
Revenue YoY (Umsatz YoY)
25.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
KURA
Peer-Median
KURA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
22 Analysten
- Starker Kauf 6 27,3%
- Kauf 13 59,1%
- Halten 3 13,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-19
Median
$28.00
← Unter allen Zielen
$12.53
Tief
$15.00
Hoch
$76.00
Median-Ziel
$28.00
+123,5%
Mittelwert-Ziel
$32.00
+155,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.17%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.77 | $-0.90 | 0.13% |
| 31. März 2026 | $-0.83 | $-0.65 | -0.18% |
| 31. Dezember 2025 | $-0.92 | $-0.49 | -0.43% |
| 30. September 2025 | $-0.85 | $-0.87 | 0.02% |
| 30. Juni 2025 | $-0.75 | $-0.47 | -0.28% |
| 31. März 2025 | $-0.66 | $-0.40 | -0.26% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| ODTX | — | — | — | — | — | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $67M | $54M | $0 | |
| R&D Expense | $251M | $170M | $115M | |
| SG&A Expense | $120M | $77M | $51M | |
| Operating Expenses | $371M | $247M | $166M | |
| Operating Income | $-304M | $-193M | $-166M | |
| Interest Expense | · | · | $2M | |
| Other Non-op | $25M | $21M | $13M | |
| Pretax Income | $-278M | $-172M | $-153M | |
| Income Tax | $297.0K | $2M | $0 | |
| Net Income | $-279M | $-174M | $-153M | |
| EPS (Basic) | $-3.18 | $-2.02 | $-2.08 | |
| EPS (Diluted) | $-3.18 | $-2.02 | $-2.08 | |
| Shares (Basic) | 87,676,000 | 86,161,000 | 73,229,000 | |
| Shares (Diluted) | 87,676,000 | 86,161,000 | 73,229,000 | |
| EBITDA | $-304M | $-193M | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $149M | $224M | $37M | |
| Receivables | $9M | $2M | · | |
| Inventory | $413.0K | $0 | · | |
| Prepaid Expense | $32M | $15M | $9M | |
| Current Assets | $709M | $745M | $432M | |
| PP&E (Net) | $8M | $2M | $2M | |
| PP&E (Gross) | $11M | $5M | $4M | |
| Accum. Depreciation | $3M | $3M | $2M | |
| Other Non-current Assets | $15M | $8M | $8M | |
| Total Assets | $738M | $760M | $449M | |
| Accounts Payable | $5M | $1M | $2M | |
| Current Liabilities | $117M | $79M | $35M | |
| Capital Leases | $9M | $5M | $6M | |
| Other Non-current Liabilities | $3M | $2M | $705.0K | |
| Total Liabilities | $564M | $347M | $52M | |
| Long-term Debt | $10M | $10M | · | |
| Total Debt | $10M | $10M | $9M | |
| Common Stock | $9.0K | $8.0K | $7.0K | |
| Retained Earnings | $-1.17B | $-895M | $-721M | |
| AOCI | $1M | $764.0K | $-1M | |
| Stockholders' Equity | $174M | $414M | $397M | |
| Liabilities + Equity | $738M | $760M | $449M | |
| Shares Outstanding | 87,855,000 | 78,229,000 | 74,350,000 |
Cashflow 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $37M | $34M | $28M | |
| Operating Cash Flow | $-64M | $134M | $-125M | |
| CapEx | $7M | $472.0K | $168.0K | |
| Investing Cash Flow | $-13M | $-102M | $16M | |
| Financing Cash Flow | $2M | $154M | $95M | |
| Net Change in Cash | $-75M | $187M | $-14M | |
| Taxes Paid | $2M | · | · | |
| Free Cash Flow | $-71M | $134M | $-125M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -449.9% | -358.6% | · | |
| Net Margin | -413.0% | -322.9% | · | |
| Pretax Margin | -412.5% | -319.1% | · | |
| EBITDA Margin | -449.9% | -358.6% | · | |
| ROA | -37.2% | -28.8% | -33.7% | |
| ROE | -116.2% | -41.5% | -36.9% | |
| ROIC | -165.3% | -46.2% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 6.1 | 9.5 | 12.3 | |
| Quick Ratio | 1.3 | 2.9 | 1.1 | |
| Debt / Equity | 0.1 | 0.0 | 0.0 | |
| LT Debt / Equity | 0.1 | 0.0 | 0.0 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | |
| Receivables Turnover | 12.4 | · | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 25.2% | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $67M | $54M | $0 | |
| Net Income TTM | $-279M | $-174M | $-153M | |
| Market Cap | $913M | $681M | $1.07B | |
| Enterprise Value | $773M | $466M | $1.04B | |
| P/E | -3.3 | -4.3 | -6.9 | |
| P/S | 13.5 | 12.6 | · | |
| P/B | 5.2 | 1.6 | 2.7 | |
| P / Tangible Book | 5.2 | 1.6 | 2.7 | |
| P / Cash Flow | -14.2 | 5.1 | -8.6 | |
| P / FCF | -12.9 | 5.1 | -8.6 | |
| EV / EBITDA | -2.5 | -2.4 | · | |
| EV / FCF | -10.9 | 3.5 | -8.3 | |
| EV / Revenue | 11.5 | 8.7 | · | |
| Earnings Yield | -30.6% | -23.2% | -14.5% |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $21M | $18M | $17M | $21M | $15M | $14M | |
| Cost of Revenue | $243.0K | $262.0K | · | · | · | · | |
| R&D Expense | $62M | $65M | $64M | $68M | $63M | $56M | |
| SG&A Expense | $32M | $32M | $39M | $33M | $25M | $23M | |
| Operating Expenses | $94M | $97M | $104M | $101M | $88M | $79M | |
| Operating Income | $-73M | $-79M | $-86M | $-80M | $-73M | $-65M | |
| Other Non-op | $5M | $5M | $5M | $6M | $7M | $7M | |
| Pretax Income | $-68M | $-73M | $-81M | $-74M | $-66M | $-57M | |
| Income Tax | $5.0K | $8.0K | $71.0K | $0 | $0 | $226.0K | |
| Net Income | $-68M | $-73M | $-81M | $-74M | $-66M | $-57M | |
| EPS (Basic) | $-0.77 | $-0.83 | $-0.92 | $-0.85 | $-0.75 | $-0.66 | |
| EPS (Diluted) | $-0.77 | $-0.83 | $-0.92 | $-0.85 | $-0.75 | $-0.66 | |
| Shares (Basic) | 88,855,000 | 88,610,000 | -174,970,000 | 87,645,000 | 87,586,000 | 87,415,000 | |
| Shares (Diluted) | 88,855,000 | 88,610,000 | -174,970,000 | 87,645,000 | 87,586,000 | 87,415,000 | |
| EBITDA | $-73M | $-79M | · | $-80M | $-73M | $-65M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70M | $39M | $149M | $95M | $82M | $51M | |
| Receivables | $9M | $9M | $9M | $36M | $5M | $49M | |
| Inventory | $2M | $843.0K | $413.0K | · | · | · | |
| Prepaid Expense | $28M | $33M | $32M | $35M | $25M | $17M | |
| Current Assets | $559M | $624M | $709M | $621M | $660M | $724M | |
| PP&E (Net) | $8M | $8M | $8M | $7M | $4M | $2M | |
| PP&E (Gross) | $11M | $11M | $11M | $11M | $8M | $6M | |
| Accum. Depreciation | $4M | $3M | $3M | $4M | $4M | $4M | |
| Other Non-current Assets | $14M | $14M | $15M | $14M | $11M | $9M | |
| Total Assets | $588M | $653M | $738M | $649M | $682M | $744M | |
| Accounts Payable | $2M | $7M | $5M | $5M | $2M | $5M | |
| Current Liabilities | $118M | $101M | $117M | $121M | $107M | $90M | |
| Capital Leases | $13M | $13M | $9M | $8M | $8M | $8M | |
| Other Non-current Liabilities | $4M | $3M | $3M | $3M | $3M | $2M | |
| Total Liabilities | $539M | $545M | $564M | $407M | $377M | $379M | |
| Long-term Debt | $10M | · | $10M | $10M | $10M | $10M | |
| Total Debt | $10M | $10M | · | $10M | $10M | $10M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | |
| Retained Earnings | $-1.32B | $-1.25B | $-1.17B | $-1.09B | $-1.02B | $-953M | |
| AOCI | · | · | $1M | · | $711.0K | $974.0K | |
| Stockholders' Equity | $48M | $108M | $174M | $243M | $305M | $364M | |
| Liabilities + Equity | $588M | $653M | $738M | $649M | $682M | $744M | |
| Shares Outstanding | 88,954,000 | 88,763,000 | 87,855,000 | 87,016,000 | 86,797,000 | 80,778,000 |
Cashflow 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $8M | $11M | $11M | $7M | $8M | |
| Operating Cash Flow | $-63M | $-86M | $117M | $-81M | $-29M | $-72M | |
| CapEx | $656.0K | $128.0K | $2M | $3M | $1M | $292.0K | |
| Investing Cash Flow | $92M | $-24M | $-65M | $94M | $59M | $-101M | |
| Financing Cash Flow | $1M | $69.0K | $1M | $0 | $515.0K | $143.0K | |
| Net Change in Cash | $31M | $-110M | $54M | $13M | $31M | $-173M | |
| Free Cash Flow | · | $-86M | · | · | · | $-72M |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -349.8% | -431.5% | · | -385.5% | -475.3% | -458.6% | |
| Net Margin | -327.3% | -401.5% | · | -357.2% | -432.5% | -407.1% | |
| Pretax Margin | -327.3% | -401.4% | · | -357.2% | -432.5% | -405.5% | |
| EBITDA Margin | -349.8% | -431.5% | · | -385.5% | -475.3% | -458.6% | |
| ROA | -10.8% | -10.5% | · | -13.1% | -11.0% | -8.8% | |
| ROE | -38.6% | -31.1% | · | -22.2% | -17.1% | -13.2% | |
| ROIC | -125.4% | -67.0% | · | · | · | -17.4% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 6.1 | · | 5.1 | 6.2 | 8.1 | |
| Quick Ratio | 0.7 | 0.5 | · | 1.1 | 0.8 | 1.1 | |
| Debt / Equity | 0.2 | 0.1 | · | 0.0 | 0.0 | 0.0 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.2 | 0.6 | · | · | · | · | |
| Receivables Turnover | 3.0 | 0.6 | · | 1.2 | 6.7 | 0.6 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $75M | $68M | · | · | · | · | |
| Net Income TTM | $-282M | $-271M | · | $-252M | $-229M | $-212M | |
| Market Cap | $976M | $722M | · | $770M | $501M | $533M | |
| Enterprise Value | $915M | $692M | · | $684M | $428M | $491M | |
| P/E | -3.4 | -2.6 | · | -3.1 | -2.2 | -2.7 | |
| P/S | 13.0 | 10.5 | · | · | · | · | |
| P/B | 20.1 | 6.7 | · | 3.2 | 1.6 | 1.5 | |
| P / Tangible Book | 20.1 | 6.7 | · | 3.2 | 1.6 | 1.5 | |
| P / Cash Flow | · | -8.4 | · | · | · | -7.4 | |
| P / FCF | · | -8.4 | · | · | · | -7.4 | |
| EV / EBITDA | -12.5 | -8.8 | · | -8.6 | -5.9 | -7.6 | |
| EV / FCF | · | -8.1 | · | · | · | -6.8 | |
| EV / Revenue | 12.2 | 10.1 | · | · | · | · | |
| Earnings Yield | -29.2% | -38.0% | · | -32.7% | -45.6% | -37.4% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $67M | $54M | $0 | — | — |
| Betriebsgewinnmarge % | -449.9% | -358.6% | — | — | — |
| Nettoergebnis | $-279M | $-174M | $-153M | $-136M | $-130M |
| Verwässerte EPS | $-3.18 | $-2.02 | $-2.08 | $-2.03 | $-1.97 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.1 | 0.0 | 0.0 | 0.0 | — |
| Liquiditätsgrad | 6.1 | 9.5 | 12.3 | 18.6 | 23.3 |
| Quick Ratio | 1.3 | 2.9 | 1.1 | 2.2 | 4.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-71M | $134M | $-125M | $-111M | $-106M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 237 Einreicher · $736.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 33 (+2 vs. Vorquartal) | 23 (-2 vs. Vorquartal) | 79 (+8 vs. Vorquartal) | 66 (-10 vs. Vorquartal) | +6.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $94.072.379 | 8.575.422 | 12,78% | Aktien |
| BVF INC/IL | $92.650.086 | 8.445.769 | 12,59% | Aktien |
| STATE STREET CORP | $58.461.412 | 5.329.208 | 7,94% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $42.960.319 | 3.916.164 | 5,84% | Aktien |
| ARMISTICE CAPITAL, LLC | $40.347.660 | 3.678.000 | 5,48% | Aktien |
| ALETHEA CAPITAL MANAGEMENT, LLC | $23.782.280 | 2.167.938 | 3,23% | Aktien |
| Prosight Management, LP | $22.180.945 | 2.021.964 | 3,01% | Aktien |
| Deep Track Capital, LP | $21.704.858 | 1.978.565 | 2,95% | Aktien |
| GOLDMAN SACHS GROUP INC | $21.431.551 | 1.953.651 | 2,91% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $20.956.569 | 1.909.862 | 2,85% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $18.251.502 | 1.663.765 | 2,48% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $15.470.717 | 1.410.275 | 2,10% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $14.589.453 | 1.329.941 | 1,98% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $12.888.434 | 1.174.880 | 1,75% | Aktien |
| Qube Research & Technologies Ltd | $12.833.627 | 1.169.884 | 1,74% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $12.071.125 | 1.100.376 | 1,64% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $10.922.500 | 995.670 | 1,48% | Aktien |
| BANK OF AMERICA CORP /DE/ | $10.773.889 | 982.123 | 1,46% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $10.410.245 | 948.974 | 1,41% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.803.312 | 711.332 | 1,06% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.420.108 | 676.400 | 1,01% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.906.273 | 629.560 | 0,94% | Aktien |
| Fisher Asset Management, LLC | $6.866.520 | 625.936 | 0,93% | Aktien |
| ROYCE & ASSOCIATES LP | $6.691.535 | 609.985 | 0,91% | Aktien |
| Rhenman & Partners Asset Management AB | $6.488.755 | 591.500 | 0,88% | Aktien |
| BlackRock, Inc. | $5.984.201 | 545.506 | 0,81% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $5.593.449 | 509.886 | 0,76% | Aktien |
| 1492 Capital Management LLC | $5.124.668 | 467.153 | 0,70% | Aktien |
| SECTOR GAMMA AS | $4.750.142 | 433.012 | 0,65% | Aktien |
| Man Group plc | $4.749.001 | 432.908 | 0,65% | Aktien |
| IEQ CAPITAL, LLC | $3.818.934 | 348.125 | 0,52% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $3.772.484 | 343.891 | 0,51% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.526.855 | 321.500 | 0,48% | Kaufoption |
| MORGAN STANLEY | $3.302.798 | 301.075 | 0,45% | Aktien |
| FMR LLC | $3.263.553 | 297.498 | 0,44% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $3.236.578 | 295.039 | 0,44% | Aktien |
| OP Asset Management Ltd | $3.201.924 | 291.880 | 0,44% | Aktien |
| Ally Bridge Group (NY) LLC | $3.181.300 | 290.000 | 0,43% | Aktien |
| Ishara Investments LP | $3.035.948 | 276.750 | 0,41% | Aktien |
| Assenagon Asset Management S.A. | $2.937.196 | 267.748 | 0,40% | Aktien |
| CITADEL ADVISORS LLC | $2.885.615 | 263.046 | 0,39% | Aktien |
| GREAT LAKES ADVISORS, LLC | $2.811.918 | 256.328 | 0,38% | Aktien |
| PRUDENTIAL FINANCIAL INC | $2.419.434 | 220.550 | 0,33% | Aktien |
| Quantinno Capital Management LP | $2.267.817 | 206.728 | 0,31% | Aktien |
| AMERIPRISE FINANCIAL INC | $2.226.449 | 202.958 | 0,30% | Aktien |
| Trexquant Investment LP | $2.015.529 | 183.731 | 0,27% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.838.364 | 167.581 | 0,25% | Aktien |
| Swedbank AB | $1.677.313 | 152.900 | 0,23% | Aktien |
| Mariner, LLC | $1.626.381 | 148.257 | 0,22% | Aktien |
| Woodline Partners LP | $1.598.373 | 145.704 | 0,22% | Aktien |
| Swiss National Bank | $1.597.232 | 145.600 | 0,22% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.585.514 | 152.600 | 0,22% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $1.573.564 | 159.724 | 0,21% | Aktien |
| BARCLAYS PLC | $1.547.033 | 141.024 | 0,21% | Aktien |
| Engineers Gate Manager LP | $1.467.216 | 133.748 | 0,20% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $1.413.946 | 128.892 | 0,19% | Aktien |
| Virtus Investment Advisers, LLC | $1.409.590 | 128.495 | 0,19% | Aktien |
| Corient Private Wealth LP | $1.343.727 | 122.491 | 0,18% | Aktien |
| CITIGROUP INC | $1.336.552 | 121.837 | 0,18% | Aktien |
| DAFNA Capital Management LLC | $1.322.631 | 120.568 | 0,18% | Aktien |
| RHUMBLINE ADVISERS | $1.190.674 | 108.540 | 0,16% | Aktien |
| Rosalind Advisors, Inc. | $1.097.000 | 100.000 | 0,15% | Aktien |
| HSBC HOLDINGS PLC | $1.055.235 | 94.810 | 0,14% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.045.112 | 95.270 | 0,14% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $1.033.352 | 94.198 | 0,14% | Aktien |
| Rangeley Capital, LLC | $1.031.180 | 94.000 | 0,14% | Aktien |
| CWM, LLC | $1.005.567 | 123.686 | 0,14% | Aktien |
| Xcel Wealth Management, LLC | $998.084 | 90.983 | 0,14% | Aktien |
| ALPS ADVISORS INC | $988.320 | 90.093 | 0,13% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $975.233 | 88.900 | 0,13% | Aktien |
| Rafferty Asset Management, LLC | $937.781 | 85.486 | 0,13% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $873.082 | 79.588 | 0,12% | Aktien |
| Bank of New York Mellon Corp | $821.894 | 74.922 | 0,11% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $815.312 | 74.322 | 0,11% | Aktien |
| Jain Global LLC | $798.945 | 72.830 | 0,11% | Aktien |
| SECTORAL ASSET MANAGEMENT INC | $784.136 | 71.480 | 0,11% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $774.927 | 95.317 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $759.124 | 69.200 | 0,10% | Kaufoption |
| Aaron Wealth Advisors LLC | $739.981 | 67.455 | 0,10% | Aktien |
| Nebula Research & Development LLC | $703.271 | 121.884 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $689.424 | 84.800 | 0,09% | Aktien |
| JANE STREET GROUP, LLC | $644.586 | 58.759 | 0,09% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $626.859 | 57.143 | 0,09% | Aktien |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $621.341 | 56.640 | 0,08% | Aktien |
| Pale Fire Capital SE | $620.902 | 56.600 | 0,08% | Aktien |
| Quadrature Capital Ltd | $611.183 | 55.714 | 0,08% | Aktien |
| Cubist Systematic Strategies, LLC | $611.004 | 69.040 | 0,08% | Aktien |
| Knott David M Jr | $578.854 | 52.767 | 0,08% | Aktien |
| MetLife Investment Management, LLC | $546.986 | 49.862 | 0,07% | Aktien |
| FOX RUN MANAGEMENT, L.L.C. | $543.158 | 49.513 | 0,07% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $540.536 | 49.274 | 0,07% | Aktien |
| Lion Point Capital, LP | $504.620 | 46.000 | 0,07% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $500.682 | 45.641 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $485.971 | 44.300 | 0,07% | Verkaufsoption |
| TUDOR INVESTMENT CORP ET AL | $477.414 | 43.520 | 0,06% | Aktien |
| PROFUND ADVISORS LLC | $475.506 | 43.346 | 0,06% | Aktien |
| SEI INVESTMENTS CO | $440.640 | 40.175 | 0,06% | Aktien |
| ADAR1 Capital Management, LLC | $438.800 | 40.000 | 0,06% | Aktien |
| AlphaQuest LLC | $438.302 | 42.185 | 0,06% | Aktien |
| VANGUARD GROUP INC | $410.592 | 39.518 | 0,06% | Aktien |
Unternehmensinsider 30 Insider · 19 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marc Grasso | CFO, CBO | 26. Januar 2022 A | 21.900 | 0 | 0 | $0 |
| Heidi Henson | Chief Financial Officer | 24. Januar 2018 A | — | 0 | 0 | $0 |
| Matthew P Kinley | Secretary, CFO | 6. März 2015 D | 0 | 0 | 0 | $0 |
| John Pappajohn | President | 6. März 2015 D | 0 | 0 | 0 | $0 |
| Kathleen Ford | Chief Operating Officer | 19. Mai 2026 S | 153.560 | 0 | 4 | $-174.610 |
| John Farnam | Chief Operating Officer | 22. Januar 2019 A | — | 0 | 0 | $0 |
| Mollie Leoni | Chief Medical Officer | 18. Juni 2026 S | 182.345 | 0 | 7 | $-1.186.414 |
| Brian T. Powl | Chief Commercial Officer | 21. Mai 2026 S | 173.614 | 0 | 6 | $-346.227 |
| Teresa Brophy Bair | Chief Legal Officer | 18. Mai 2026 S | 226.931 | 0 | 6 | $-293.126 |
| Francis Burrows | Chief Scientific Officer | 27. Januar 2026 S | 32.424 | 0 | 2 | $-243.131 |
| Thomas James Doyle | SVP, Finance & Accounting | 27. Januar 2026 S | 145.167 | 0 | 7 | $-151.764 |
| Stephen Dale | Chief Medical Officer | 30. Januar 2024 S | 38.817 | 0 | 0 | $0 |
| Kirsten Flowers | CCO & Chief Strategy Officer | 27. Januar 2023 S | 20.605 | 0 | 0 | $0 |
| James Basta | Chief Legal Officer | 26. Januar 2021 A | — | 0 | 0 | $0 |
| Bridget A Martell | Acting Chief Medical Officer | 10. Februar 2020 A | — | 0 | 0 | $0 |
| Antonio Gualberto | Head of Development & CMO | 10. Juli 2019 M | 339.973 | 0 | 0 | $0 |
| Pingda Ren | SVP Chemistry&Pharma Sciences | 22. Januar 2019 A | — | 0 | 0 | $0 |
| Annette North | SVP, General Counsel | 22. Januar 2019 A | — | 0 | 0 | $0 |
| Yi Liu | Chief Scientific Officer | 24. Januar 2018 A | — | 0 | 0 | $0 |
| Diane L. Parks | Direktor | 4. Juni 2026 A | — | 0 | 0 | $0 |
| Michael Vasconcelles | Direktor | 4. Juni 2026 A | — | 0 | 0 | $0 |
| Helen Louise Collins | Direktor | 4. Juni 2026 A | — | 0 | 0 | $0 |
| Mary T Szela | Direktor | 4. Juni 2026 A | — | 0 | 0 | $0 |
| Thomas Malley | Direktor | 4. Juni 2026 A | 10.000 | 0 | 0 | $0 |
| Faheem Hasnain | Direktor | 4. Juni 2026 A | 23.983 | 0 | 1 | $-109.800 |
| Carol Schafer | Direktor | 4. Juni 2026 A | — | 0 | 0 | $0 |
| Steven H Stein | Direktor | 21. Juni 2022 A | — | 0 | 0 | $0 |
| Robert Hoffman | Direktor | 22. Juni 2021 A | — | 0 | 0 | $0 |
| Argyris Vassiliou | 10%-Eigentümer | 6. März 2015 D | 0 | 0 | 0 | $0 |
| Troy Edward Wilson | — | 17. August 2026 P | 379.194 | 1 | 1 | $784.662 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter | 4. April 2008 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 4. April 2008 | — | Erste Einreichung | — | SEC |
| Argyris Vassiliou | 4. April 2008 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 45 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,38% | 92.599 NS | 30. April 2026 | N-PORT |
| IDNA · iShares Trust | 0,88% | 186.448 SH | 8. August 2026 | Täglich |
| SBIO · ALPS ETF Trust | 0,57% | 91.050 NS | 31. Mai 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 0,31% | 55.872 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,25% | 144.395 NS | 30. April 2026 | N-PORT |
| SMMV · iShares Trust | 0,10% | 31.723 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,08% | 75.402 NS | 31. Mai 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,07% | 13.569 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,06% | 634.884 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 91.297 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 4.829 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,05% | 780.455 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 144.698 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,04% | 3.218 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 490.002 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 2.172.167 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,02% | 16.389 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 34.913 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 3.795 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 413.820 NS | 31. Mai 2026 | N-PORT |
| TECB · iShares Trust | 0,02% | 8.727 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 2.968 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 3.379 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 34.421 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 166.511 NS | 30. April 2026 | N-PORT |
| SMLF · iShares Trust | 0,01% | 46.113 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.026.601 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 219.509 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 3.003 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 12.094 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3.659 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.660 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 75 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 154.436 NS | 30. April 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 1.215 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 7.459 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 157.024 SH | 8. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 15.106 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 47.582 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 20.425 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.953 SH | 8. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 222 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 861 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.799.338 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.461 SH | 8. August 2026 | Täglich |